With our advanced platform of Tumor Profiling to Guide Targeted Cancer Therapy, Creative Biolabs has developed an unparalleled platform for non-small cell lung tumor profiling. To fulfill every need of our consumers, our professional scientists are ready to start working on your projects.
NSCLC is the most prevalent type of lung cancer, which is the first leading category of cancer worldwide. Nowadays, personalized therapies have provided more efficient treatment options than traditional therapies, along with which the optimal treatment identification has become progressively intricate. A comprehensive tumor profiling in NSCLC could improve the therapeutic effectiveness and avoid useless effort.
Fig.1 Modern tumor profiling in lung cancer. (Cancer Genome Atlas Research Network, 2014)
Recent advances in Technologies for Tumor Profiling have provided us insight into the heterogeneity among NSCLC tumor cell populations. We provide the tumor Profiling in different biomarker expression levels with different techniques.
Technologies with tissue dissociation or liquid biopsy
→Technologies with spatial processing
→
Creative Biolabs is a world-leading services provider in the field of tumor profiling. Equipped with advanced platforms and powerful technologies, our services team is expertise and dedicated to supporting heterogeneous tumor profiling demands by developing this high-quality platform. If you are interested in our services, please contact us directly.
Reference
For Research Use Only | Not For Clinical Use
Download our brochure